Securities code: Pku Healthcare Corp.Ltd(000788) securities abbreviation: Pku Healthcare Corp.Ltd(000788) Announcement No.: 2022009 Pku Healthcare Corp.Ltd(000788)
Announcement on abnormal fluctuations in stock trading
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
1、 Introduction to abnormal fluctuations in stock trading
Pku Healthcare Corp.Ltd(000788) (hereinafter referred to as “the company”) shares (Securities abbreviation: Pku Healthcare Corp.Ltd(000788) , stock code: Pku Healthcare Corp.Ltd(000788) ) have accumulated more than 20% deviation from the closing price increase in two consecutive trading days on March 14 and March 15, 2022. According to the relevant regulations of Shenzhen Stock Exchange, it is an abnormal fluctuation of stock trading.
2、 Description of the company’s concern and verification
In view of the abnormal fluctuation of the company’s stock trading, the company checked the relevant matters and inquired the controlling shareholder and actual controller of the company. The relevant information is as follows:
1. Recently, we noticed that there are rumors on the Internet about the company’s cooperation with yanyeyi, Japan to develop covid-19 specific drug. Here, we solemnly declare that the company has never carried out the research and development of covid-19 specific drugs, nor has it discussed the cooperation with yanyeyi of Japan on covid-19 specific drugs. Please do not believe the Internet rumors, pay attention to investment risks and invest rationally.
2. After verification, there is no need to correct or supplement the information disclosed by the company in the early stage.
3. After verification, the company did not find any unpublished material information that may or has had a great impact on the company’s stock trading price reported by the public media recently.
4. After verification, the company’s current operation is normal, and the internal and external business environment has not changed significantly.
5. After verification, the controlling shareholders and actual controllers of the company do not have other major matters that should be disclosed but not disclosed about the company, nor do they have major matters involving the company in the planning stage.
6. After verification, the controlling shareholder and actual controller of the company did not buy or sell the company’s shares during the abnormal fluctuation of shares.
7. After verification, as of the date of this announcement, the equity transfer and asset delivery of the original actual controllers of the company, Peking University Founder Group Co., Ltd. and Peking University Medical Industry Group Co., Ltd., have not been completed. Due to the reorganization of Founder group, the company’s 2019 and 2020 annual reports were issued with qualified audit reports by Tianjian Certified Public Accountants on the risk of related deposits, related guarantees and overdue accounts receivable of related transactions. The above-mentioned risk matters are still uncertain.
3、 Whether there is a description of the information that should be disclosed but not disclosed
The board of directors of the company confirms that, in addition to the above matters, the company has no undisclosed matters that should be disclosed in accordance with the stock listing rules of Shenzhen Stock Exchange or planning, negotiation, intention, agreement, etc. related to the matters; The board of directors has not been informed that the company has undisclosed information that should be disclosed in accordance with the stock listing rules of Shenzhen Stock Exchange and has a great impact on the trading price of the company’s shares and their derivatives; The information disclosed by the company in the early stage does not need to be corrected or supplemented.
4、 Necessary risk tips
1. Through self-examination, the company failed to timely fulfill the obligation of information disclosure for major events with the risk of fulfilling the guarantee liability because Peking University Medical Industry Group Co., Ltd. provided guarantee for Bank Of Nanjing Co.Ltd(601009) loan of RMB 100 million, On January 29, 2022, it received the decision on Issuing warning letter to Pku Healthcare Corp.Ltd(000788) issued by Chongqing regulatory bureau of China Securities Regulatory Commission (No. [2022] 6), For details, please refer to the announcement on receiving the warning letter from Chongqing Securities Regulatory Bureau and the decision of the company’s relevant personnel on the supervision interview measures of Chongqing Securities Regulatory Bureau (Announcement No.: 2022006) disclosed by the company on February 7, 2022. The company has no other violation of fair disclosure of information.
2. As of the date of this announcement, the company’s 2021 annual report is still being prepared, there is no disclosure of performance information, the company does not need to disclose performance forecast, and the unpublished periodic report data information has not been provided to a third party other than the company’s audit institution.
3. Securities times, China Securities News, Shanghai Securities News, securities daily and cninfo (www.cn. Info. Com. CN.) As the information disclosure media designated by the company, all information of the company shall be subject to the information published in the above designated media. Please invest rationally and pay attention to risks.
It is hereby announced.
Pku Healthcare Corp.Ltd(000788)
Board of directors
March 16, 2002
